Nicotine + Placebo
Pre-clinicalCompleted 0 watching 0 views this week💤 Quiet
23
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Smoking Cessation
Conditions
Smoking Cessation
Trial Timeline
Mar 1, 2009 → Jun 1, 2010
NCT ID
NCT00882375About Nicotine + Placebo
Nicotine + Placebo is a pre-clinical stage product being developed by Johnson & Johnson for Smoking Cessation. The current trial status is completed. This product is registered under clinical trial identifier NCT00882375. Target conditions include Smoking Cessation.
Hype Score Breakdown
Clinical
5
Activity
2
Company
10
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00882375 | Pre-clinical | Completed |
Competing Products
20 competing products in Smoking Cessation